Headache Syndromes: Diagnostic and Management Approach for Primary and Secondary Headaches

Headaches are among the most common neurological complaints encountered in clinical practice, affecting up to 96% of the population at some point in their lives. The International Classification of Headache Disorders (ICHD-3) provides a comprehensive framework for understanding these complex conditions, dividing headaches into three major categories: primary headaches, secondary headaches, and cranial neuralgias.

Primary headaches account for approximately 90% of all headache presentations and include migraine, tension-type headache, and cluster headache. These disorders are not caused by underlying structural abnormalities but rather represent dysfunction in pain-processing pathways, neurovascular mechanisms, or muscle tension patterns.

Secondary headaches result from underlying pathology such as intracranial masses, infections, vascular disorders, or medication overuse. While less common, these require immediate recognition due to their potential for serious morbidity and mortality.

The approach to headache evaluation begins with a thorough history focusing on headache characteristics using the mnemonic SOCRATES: Site, Onset, Character, Radiation, Associations, Time course, Exacerbating/relieving factors, and Severity. Key historical elements include:

• Temporal pattern: Frequency, duration, and progression over time
• Pain characteristics: Quality, intensity (1-10 scale), location
• Associated symptoms: Nausea, vomiting, photophobia, phonophobia, aura
• Triggers: Stress, foods, hormonal changes, sleep patterns
• Response to treatment: Previous medications tried and their effectiveness

Physical examination should include vital signs, neurological assessment, fundoscopic examination, and evaluation for meningeal signs. The presence of focal neurological deficits, papilledema, or fever should prompt immediate investigation for secondary causes.

Red flag symptoms that warrant urgent evaluation include:

• Sudden onset "thunderclap" headache
• New headache in patients >50 years old
• Progressive worsening over weeks to months
• Headache with fever, neck stiffness, or altered mental status
• New headache in immunocompromised patients
• Headache with focal neurological signs

Migraine is a complex neurovascular disorder affecting approximately 12% of the population, with a 3:1 female predominance. The pathophysiology involves dysfunction of the trigeminovascular system, cortical spreading depression, and altered brainstem pain processing.

Pathophysiological mechanisms include:

1. Cortical spreading depression: A wave of neuronal depolarization followed by prolonged suppression that may trigger aura symptoms
2. Trigeminovascular activation: Stimulation of trigeminal nerve endings around blood vessels releases vasoactive peptides (CGRP, substance P)
3. Central sensitization: Enhanced pain processing in brainstem nuclei leads to allodynia and hyperalgesia

Clinical phases of migraine:

Diagnostic criteria (ICHD-3) for migraine without aura require:

• At least 5 attacks lasting 4-72 hours
• At least 2 of: unilateral location, pulsating quality, moderate-severe intensity, aggravation by physical activity
• At least 1 of: nausea/vomiting, photophobia and phonophobia
• Not better accounted for by another diagnosis

Migraine with aura includes fully reversible visual, sensory, or speech/language symptoms developing gradually over ≥5 minutes, lasting 5-60 minutes, followed by headache within 60 minutes.

Common triggers include:

• Hormonal changes (menstruation, oral contraceptives)
• Dietary factors (aged cheese, alcohol, MSG, chocolate)
• Environmental factors (bright lights, strong odors)
• Sleep disturbances (too little or too much sleep)
• Stress and emotional factors
• Weather changes and barometric pressure

Subtypes include chronic migraine (≥15 headache days per month), hemiplegic migraine, and status migrainosus (>72 hours duration).

Tension-type headache (TTH) is the most prevalent primary headache disorder, affecting up to 70% of the population. It represents a spectrum from infrequent episodic to chronic daily headache, with significant impact on quality of life and healthcare utilization.

Pathophysiology remains incompletely understood but involves:

• Peripheral mechanisms: Increased muscle tenderness and trigger points in pericranial muscles
• Central sensitization: Enhanced pain processing in the central nervous system
• Stress and psychological factors: Strong association with anxiety, depression, and stress

Clinical features of tension-type headache:

• Pain character: Pressing or tightening quality, described as "band-like" or "vice-like"
• Location: Bilateral, often involving forehead, temples, or occipital region
• Intensity: Mild to moderate severity (4-6/10)
• Duration: 30 minutes to 7 days
• Associated symptoms: Generally absent (no nausea, vomiting, photophobia, or phonophobia)
• Activity: Not aggravated by routine physical activity

Classification based on frequency:

Diagnostic criteria require:

• At least 10 previous headache episodes
• Lasting 30 minutes to 7 days
• At least 2 of: bilateral location, pressing/tightening quality, mild-moderate intensity, not aggravated by physical activity
• Both: no nausea or vomiting; no more than one of photophobia or phonophobia

Management approach:

Acute treatment:

• First-line: Acetaminophen 1000 mg or NSAIDs (ibuprofen 400-600 mg, naproxen 220-440 mg)
• Second-line: Combination analgesics (caffeine-containing preparations)
• Avoid medication overuse (>10 days/month simple analgesics, >3 days/month combination medications)

Preventive treatment (for frequent episodic or chronic TTH):

• Tricyclic antidepressants (amitriptyline 10-75 mg daily)
• Stress management and relaxation techniques
• Regular sleep hygiene and exercise
• Cognitive behavioral therapy

Cluster headache is a rare but extremely severe primary headache disorder, often called "suicide headache" due to its excruciating intensity. It affects approximately 0.1% of the population with a male predominance (3:1 ratio) and typically begins in the third decade of life.

Pathophysiology involves:

• Hypothalamic dysfunction: Dysfunction of the posterior hypothalamus disrupts circadian rhythms
• Trigeminal-autonomic reflex: Activation causes severe pain and autonomic features
• Vascular changes: Carotid artery inflammation and venous congestion
• Circadian patterns: Strong association with sleep-wake cycles and seasonal variations

Clinical features:

• Pain character: Severe, boring, burning, or stabbing quality (10/10 intensity)
• Location: Strictly unilateral, periorbital, temporal, or supraorbital
• Duration: 15-180 minutes if untreated
• Frequency: 1-8 attacks per day during cluster periods
• Pattern: Cluster periods lasting weeks to months, followed by remission periods

Autonomic features (ipsilateral to pain):

• Conjunctival injection and lacrimation
• Nasal congestion and rhinorrhea
• Eyelid edema and ptosis
• Miosis (constricted pupil)
• Forehead and facial sweating
• Restlessness and agitation (unlike migraine patients who prefer stillness)

Diagnostic criteria require:

• At least 5 attacks of severe unilateral pain lasting 15-180 minutes
• At least 1 ipsilateral autonomic feature
• Frequency: 1 every other day to 8 per day
• Not better accounted for by another diagnosis

Classification:

• Episodic cluster headache (90%): Cluster periods lasting 7 days to 1 year, separated by remissions ≥3 months
• Chronic cluster headache (10%): Attacks for >1 year without remission or with remissions <3 months

Acute treatment:

Cluster Headache Acute Management Algorithm:

Severe unilateral headache + autonomic features ↓ First-line options (choose one):

• High-flow oxygen 100% at 12-15 L/min × 15 minutes
• Sumatriptan 6 mg SC (onset 10-15 minutes)
• Zolmitriptan 5-10 mg intranasal ↓ If ineffective after 20 minutes:
• Try alternative first-line option
• Consider octreotide 100 μg SC ↓ Preventive therapy if >2 attacks/week

Triggers during cluster periods:

• Alcohol (most common and reliable trigger)
• Strong odors (perfumes, paint fumes)
• Nitroglycerin and other vasodilators
• Daytime napping
• High altitude

Recognition of secondary headaches is crucial as they may indicate life-threatening conditions requiring immediate intervention. Approximately 10% of headaches are secondary, but they account for the majority of headache-related morbidity and mortality.

Critical red flag symptoms requiring immediate evaluation:

SNOOP mnemonic for red flags:

• Systemic symptoms (fever, weight loss)
• Neurological symptoms (focal deficits, altered consciousness)
• Onset sudden (thunderclap pattern)
• Older age (new headache >50 years)
• Previous headache history (change in pattern)

High-risk secondary headache syndromes:

1. Subarachnoid Hemorrhage (SAH)

• Sudden onset "worst headache ever"
• May have brief loss of consciousness
• Neck stiffness, photophobia, vomiting
• CT head (non-contrast) within 6 hours has 95% sensitivity
• Lumbar puncture if CT negative and high suspicion

2. Giant Cell Arteritis (GCA)

• New headache in patients >50 years
• Temporal artery tenderness, jaw claudication
• Visual symptoms (diplopia, transient vision loss)
• ESR >50 mm/hr, CRP elevated
• Urgent ophthalmology consultation for vision changes

3. Meningitis/Encephalitis

• Headache + fever + neck stiffness (classic triad present in only 44%)
• Altered mental status, rash
• Lumbar puncture after ruling out increased ICP
• Empirical antibiotics if bacterial meningitis suspected

4. Idiopathic Intracranial Hypertension (IIH)

• Chronic daily headache, worse in morning
• Transient visual obscurations
• Papilledema on fundoscopy
• Young, obese women most commonly affected

5. Medication Overuse Headache (MOH)

• Chronic daily headache (≥15 days/month)
• Regular use of acute headache medications >10-15 days/month
• Headache worsens with medication withdrawal
• Requires detoxification and preventive therapy

The diagnostic workup for suspected secondary headache should be systematic, cost-effective, and tailored to clinical presentation. The decision to pursue neuroimaging and laboratory studies depends on red flag symptoms, physical examination findings, and headache characteristics.

Initial Assessment Algorithm:

Headache Presentation ↓ Detailed history + physical examination ↓ Red flags present? → YES → Immediate workup ↓ NO First headache or change in pattern? → YES → Consider workup ↓ NO Meets criteria for primary headache? → YES → Symptomatic treatment ↓ NO Consider secondary causes

Neuroimaging Indications:

Emergent CT head (non-contrast):

• Thunderclap headache
• Headache with altered consciousness
• New focal neurological deficits
• Headache with fever and meningeal signs
• Head trauma with headache
• New severe headache in elderly

Urgent MRI brain:

• Progressive headache over weeks
• New headache in cancer patient
• Headache with papilledema
• Chronic daily headache not responding to treatment
• Unusual headache features

Laboratory Studies Algorithm:

Clinical Suspicion for:

Infection → CBC with diff, blood cultures, ESR, CRP LP if meningitis suspected

Vasculitis → ESR, CRP, ANA, RF Temporal artery biopsy if GCA suspected

Endocrine → TSH, glucose Cortisol if pituitary pathology suspected

Malignancy → CBC, comprehensive metabolic panel Tumor markers if indicated

Lumbar Puncture Indications:

• Suspected meningitis/encephalitis
• Subarachnoid hemorrhage with negative CT
• Suspected idiopathic intracranial hypertension
• Carcinomatous meningitis evaluation

Opening pressure normal values: 10-20 cmH₂O (adults)

CSF Analysis Interpretation:

Management Principles for Secondary Headaches:

1. Treat underlying condition: Address root cause rather than symptoms alone
2. Multidisciplinary approach: Neurology, ophthalmology, infectious disease as needed
3. Monitor treatment response: Follow-up imaging or studies as indicated
4. Avoid masking symptoms: Minimize analgesics that might obscure progression
5. Patient education: Clear instructions for when to seek immediate care

Effective management of primary headaches requires a comprehensive approach combining acute treatment, preventive therapy when indicated, lifestyle modifications, and patient education. Treatment goals include reducing attack frequency, severity, and duration while improving quality of life.

Acute Treatment Principles:

• Treat early in the attack when pain is mild
• Use adequate doses of appropriate medications
• Limit acute medication use to prevent medication overuse headache
• Consider non-pharmacological approaches

Migraine Acute Treatment Algorithm:

Migraine Attack ↓ Mild-moderate intensity → Analgesics:

• Aspirin 900-1000 mg OR
• Ibuprofen 400-600 mg OR
• Naproxen 500-550 mg OR
• Acetaminophen 1000 mg ↓ If ineffective or moderate-severe Triptans (contraindicated in cardiovascular disease):
• Sumatriptan 50-100 mg PO, 25 mg PR, 6 mg SC, 20 mg nasal
• Rizatriptan 10 mg PO
• Eletriptan 40 mg PO ↓ If nausea/vomiting prominent Antiemetics:
• Metoclopramide 10 mg IV/IM + analgesic
• Prochlorperazine 10 mg IV/IM

Preventive Therapy Indications:

• ≥4 headache days per month with disability
• ≥2 severe attacks per month
• Failure of acute treatments
• Medication overuse headache
• Patient preference

Migraine Prevention Options:

Lifestyle Modifications:

• Regular sleep schedule (7-9 hours nightly)
• Regular meals and adequate hydration
• Regular aerobic exercise (30 minutes, 3×/week)
• Stress management techniques
• Trigger identification and avoidance
• Limit caffeine and alcohol

Tension-Type Headache Management:

Acute treatment:

• Acetaminophen 1000 mg
• NSAIDs: ibuprofen 400-600 mg, naproxen 220-440 mg
• Limit use to <10 days/month

Prevention (chronic TTH):

• Amitriptyline 10-75 mg daily (first-line)
• Mirtazapine 15-30 mg daily
• Stress management and CBT
• Physical therapy for muscle tension

Special Populations:

Pregnancy:

• Acute: Acetaminophen preferred, avoid NSAIDs after 20 weeks
• Prevention: Avoid valproate, topiramate; consider propranolol

Pediatric (age-adjusted dosing):

• Acute: Ibuprofen, acetaminophen, sumatriptan nasal (≥12 years)
• Prevention: Propranolol, topiramate, amitriptyline

Elderly:

• Start low, go slow with medications
• Consider drug interactions and comorbidities
• Increased risk of secondary headaches

Patient Education Points:

• Headache diary for trigger identification
• Medication overuse headache risks
• When to seek emergency care
• Realistic expectations for treatment response
• Importance of lifestyle modifications